The 'neuroadrenergic hypothesis' in hypertension: current evidence.

scientific article published on 11 December 2009

The 'neuroadrenergic hypothesis' in hypertension: current evidence. is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P356DOI10.1113/EXPPHYSIOL.2009.047381
P698PubMed publication ID20008032
P5875ResearchGate publication ID40685775

P50authorGino SeravalleQ56988550
Guido GrassiQ61303944
P2093author name stringFosca Quarti-Trevano
P2860cites workPathogenesis of hypertensionQ34274333
Brain renin-angiotensin system dysfunction in hypertension: recent advances and perspectivesQ35045333
The activity of single vasoconstrictor nerve units in hypertensionQ35074424
A sympathetic view of the sympathetic nervous system and human blood pressure regulationQ36208762
Role of the renal sympathetic nerves in the development and maintenance of hypertension in the spontaneously hypertensive rat.Q37024579
Renal medullary oxidative stress, pressure-natriuresis, and hypertensionQ37137810
Is neurogenic hypertension related to vascular inflammation of the brainstem?Q37202058
Do changes in the coupling between respiratory and sympathetic activities contribute to neurogenic hypertension?Q37469135
Tachycardia in hypertension: a saga of progress despite prejudice, confusion, and inertiaQ37554990
Relationship between central sympathetic drive and magnetic resonance imaging-determined left ventricular mass in essential hypertensionQ37587173
Assessment of sympathetic cardiovascular drive in human hypertension: achievements and perspectivesQ37590008
Integration of reflex responses in the control of blood pressure and vascular resistanceQ39811170
Plasma catecholamines and essential hypertension. An analytical reviewQ40144106
Central nervous system noradrenergic control of sympathetic outflow in normotensive and hypertensive humans.Q40516349
Arthur C. Corcoran Memorial Lecture. Sympathetic activity, vascular capacitance, and long-term regulation of arterial pressureQ41844127
Shift to an involvement of phosphatidylinositol 3-kinase in angiotensin II actions on nucleus tractus solitarii neurons of the spontaneously hypertensive rat.Q42931820
Renal sympathetic-nerve ablation for uncontrolled hypertensionQ43285253
Sympathetic nerve activity and blood pressure in normotensive backcross rats genetically related to the spontaneously hypertensive ratQ44311655
Relation between cardiac sympathetic activity and hypertensive left ventricular hypertrophyQ44504046
Sympathetic augmentation in hypertension: role of nerve firing, norepinephrine reuptake, and Angiotensin neuromodulationQ44650536
Sympathetic-mediated hypertension of awake juvenile rats submitted to chronic intermittent hypoxia is not linked to baroreflex dysfunction.Q45939574
Adrenergic, metabolic, and reflex abnormalities in reverse and extreme dipper hypertensivesQ46084499
Relationship between central sympathetic activity and stages of human hypertensionQ48010908
A spinal vasopressinergic mechanism mediates hyperosmolality-induced sympathoexcitationQ48460893
Elevated sympathetic nerve activity in borderline hypertensive humans. Evidence from direct intraneural recordings.Q51750627
P433issue5
P407language of work or nameEnglishQ1860
P921main subjectarterial hypertensionQ41861
P304page(s)581-586
P577publication date2009-12-11
P1433published inExperimental PhysiologyQ1091760
P1476titleThe 'neuroadrenergic hypothesis' in hypertension: current evidence
P478volume95

Reverse relations

cites work (P2860)
Q92512579Acute salt loading induces sympathetic nervous system overdrive in mice lacking salt-inducible kinase 1 (SIK1)
Q38151943Adipose afferent reflex: sympathetic activation and obesity hypertension.
Q48679737Age related diastolic function in amateur athletes
Q48310428Angiotensin AT1 receptors in paraventricular nucleus contribute to sympathetic activation and enhanced cardiac sympathetic afferent reflex in renovascular hypertensive rats
Q42292543Angiotensin II acting on brain AT1 receptors induces adrenaline secretion and pressor responses in the rat.
Q34534106Angiotensin II and angiotensin-(1-7) in paraventricular nucleus modulate cardiac sympathetic afferent reflex in renovascular hypertensive rats
Q35815199Angiotensin II status and sympathetic activation among hypertensive patients in Uganda: a cross-sectional study
Q34472153Angiotensin-(1-7) in paraventricular nucleus modulates sympathetic activity and cardiac sympathetic afferent reflex in renovascular hypertensive rats
Q38245885Arterial innervation in development and disease
Q45873654Artificial microRNA interference targeting AT(1a) receptors in paraventricular nucleus attenuates hypertension in rats
Q38196354Autonomic nervous system dysregulation in pediatric hypertension.
Q22306336Autonomic-Immune-Vascular Interaction: An Emerging Concept for Neurogenic Hypertension
Q36244806Beta-adrenergic receptor mediated inflammation control by monocytes is associated with blood pressure and risk factors for cardiovascular disease
Q50991341Blood pressure decrease in spontaneously hypertensive rats folowing renal denervation or dopamine β-hydroxylase inhibition with etamicastat.
Q85723642Blood pressure-decreasing effect of etamicastat alone and in combination with antihypertensive drugs in the spontaneously hypertensive rat
Q62828925Blunted sympathoinhibitory responses in obesity-related hypertension are due to aberrant central but not peripheral signalling mechanisms
Q44332515Brain opioid and nociceptin receptors are involved in regulation of bombesin-induced activation of central sympatho-adrenomedullary outflow in the rat.
Q47865079Cardiac sympathetic afferent reflex response to intermedin microinjection into paraventricular nucleus is mediated by nitric oxide and γ-amino butyric acid in hypertensive rats
Q36456727Differential TNF production by monocyte subsets under physical stress: blunted mobilization of proinflammatory monocytes in prehypertensive individuals
Q48139257Differential gene expression of three nitric oxide synthases is consistent with increased nitric oxide in the hindbrain of broilers with cold-induced pulmonary hypertension
Q37954116Disorders of blood pressure regulation-role of catecholamine biosynthesis, release, and metabolism
Q87267219Does sympathetic overactivation feature all hypertensives? Differences of sympathovagal balance according to night/day blood pressure ratio in patients with essential hypertension
Q47917498Early life stress and post-weaning high fat diet alter tyrosine hydroxylase regulation and AT1 receptor expression in the adrenal gland in a sex dependent manner.
Q42159015Effect of food on the pharmacokinetic profile of etamicastat (BIA 5-453).
Q35341894Effects on blood pressure and autonomic nervous system function of a 12-week exercise or exercise plus DASH-diet intervention in individuals with elevated blood pressure
Q48233757Endogenous hydrogen peroxide in paraventricular nucleus mediates sympathetic activation and enhanced cardiac sympathetic afferent reflex in renovascular hypertensive rats
Q38156714Evidence for the role of isometric exercise training in reducing blood pressure: potential mechanisms and future directions.
Q30354373Ganglionic GFAP + glial Gq-GPCR signaling enhances heart functions in vivo
Q33889435Genes influencing circadian differences in blood pressure in hypertensive mice
Q54378215Global identification of the genes and pathways differentially expressed in hypothalamus in early and established neurogenic hypertension.
Q48394438Impressive blood pressure and heart rate response after percutaneous renal denervation in a woman with morbid obesity and severe drug-resistant hypertension
Q36836484Increased Sympathetic Renal Innervation in Hemodialysis Patients Is the Anatomical Substrate of Sympathetic Hyperactivity in End-Stage Renal Disease
Q64906046Inflammatory Signaling in Hypertension: Regulation of Adrenal Catecholamine Biosynthesis.
Q50620942Left ventricular twisting modifications in patients with left ventricular concentric hypertrophy at increasing after-load conditions.
Q38267484Mechanisms involved in developmental programming of hypertension and renal diseases. Gender differences
Q44523641Melanocortin 3/4 receptors in paraventricular nucleus modulate sympathetic outflow and blood pressure
Q37943377Nebivolol for the treatment of heart failure
Q89425257Neurogenic hypertension: pathophysiology, diagnosis and management
Q38013692Neurogenic hypertension: revelations from genome-wide gene expression profiling
Q36824063Neuroimmune communication in hypertension and obesity: a new therapeutic angle?
Q33939221No elevated plasma catecholamine levels during sleep in newly diagnosed, untreated hypertensives
Q48194227Oxidant and enzymatic antioxidant status (gene expression and activity) in the brain of chickens with cold-induced pulmonary hypertension.
Q41943162Oxidative stress in the brain causes hypertension via sympathoexcitation
Q37846532Oxidative stress in the cardiovascular center has a pivotal role in the sympathetic activation in hypertension
Q37892042Paracrine control of vascular innervation in health and disease
Q26825107Potential clinical application of recently discovered brain mechanisms involved in hypertension
Q60162187Quantifying sympathetic neuro-haemodynamic transduction at rest in humans: insights into sex, ageing and blood pressure control
Q47160543Quantity and Quality of Carbohydrate Intake during Pregnancy, Newborn Body Fatness and Cardiac Autonomic Control: Conferred Cardiovascular Risk?
Q38122303Regulation of the sympathetic nervous system by nitric oxide and oxidative stress in the rostral ventrolateral medulla: 2012 Academic Conference Award from the Japanese Society of Hypertension
Q48983840Renal sympathetic denervation attenuates hypertension and vascular remodeling in renovascular hypertensive rats
Q42476216Role of P-glycoprotein and permeability upon the brain distribution and pharmacodynamics of etamicastat: a comparison with nepicastat.
Q46514659SOD1 gene transfer into paraventricular nucleus attenuates hypertension and sympathetic activity in spontaneously hypertensive rats
Q29999437Safety, Tolerability, and Pharmacokinetics of Etamicastat, a Novel Dopamine-β-Hydroxylase Inhibitor, in a Rising Multiple-Dose Study in Young Healthy Subjects
Q93346207Sex-specific long-term blood pressure regulation: Modeling and analysis
Q47396920Short hairpin RNA interference targeting interleukin 1 receptor type I in the paraventricular nucleus attenuates hypertension in rats
Q48234848Sleep disturbance among spontaneously hypertensive rats is mediated by an α1-adrenergic mechanism
Q36303921Stress-dependent hypertension and the role of T lymphocytes
Q37859637Sympathetic mechanisms, organ damage, and antihypertensive treatment
Q64938618Systemic angiotensin II does not increase cardiac sympathetic nerve activity in normal conscious sheep
Q44050848The benefits of endurance training in cardiomyocyte function in hypertensive rats are reversed within four weeks of detraining
Q28118905The crystal structure of human dopamine β-hydroxylase at 2.9 Å resolution
Q87473936The deadly line linking sympathetic overdrive, dipping status and vascular risk: critical appraisal and therapeutic implications
Q33805761Therapeutic strategies for targeting excessive central sympathetic activation in human hypertension
Q57791612Vascular impairment of adenosinergic system in hypertension: increased adenosine bioavailability and differential distribution of adenosine receptors and nucleoside transporters
Q42749550c-Src in paraventricular nucleus modulates sympathetic activity and cardiac sympathetic afferent reflex in renovascular hypertensive rats

Search more.